2006

• Jan
• Feb
• Mar
• Apr
• May
• June
• July
• Aug
• Sept
• Oct
• Nov
• Dec

November

	Increased mortality and risk of serious adverse events when prophylactic heparin is abruptly discontinued in patients to be started on Xigris [drotrecogin alfa (activated)] for severe sepsis - Notice to Hospitals - Eli Lilly Canada Inc. Date: 2006-12-22
	Important Safety Information on Iressa (gefitinib) - For Health Professionals - AstraZeneca Canada Inc. Date: 2006-12-12
	Important Safety Information on Attachment Handles for Portable Patient Lifts - Notice to Hospitals Date: 2006-12-08
	Important Safety Information on Xylocaine (lidocaine HCI) Jelly 2% Single Use Plastic Syringe (10 mL) - Notice to Hospitals - AstraZeneca Canada Inc. Date: 2006-12-06

November

	Safety information and corrective action on Air-Shields Isolette C2000/C2000e Infant Incubator - Notice to Hospitals - Draeger Medical Canada Inc. Date: 2006-11-27
	Association of Benzocaine Sprays with Methemoglobinemia - Notice to Hospitals - For the Public Date: 2006-11-24
	New safety information about Evra (norelgestromin and ethinyl estradiol) Transdermal System - For Health Professionals - For the Public - Janssen-Ortho Inc. Date: 2006-11-23
	Reports of Bowel Obstruction and Gastrointestinal Perforation with Rituxan (rituximab) - For Health Professionals - For the Public - Hoffmann-La Roche Limited Date: 2006-11-14

October

	Association of Avastin (bevacizumab) with hypertensive encephalopathy and reversible posterior leukoencephalopathy syndrome (RPLS) - For Health Professionals - For the Public - Hoffmann - La Roche Limited Date: 2006-10-27
	Association of CellCept (mycophenolate mofetil) and sirolimus containing immunosuppressant regimen with higher rate of acute rejection in cardiac transplant patients switched from calcineurin inhibitors - For Health Professionals - For the Public - Hoffmann-La Roche Limited Date: 2006-10-25
	Association of Syringe Infusion Pumps with a Risk of Delay in Detection of Downstream Occlusion - Notice to Hospitals Date: 2006-10-25
	Updated Safety Information on Ketek (telithromycin) and hepatic events, aggravation of myasthenia gravis and syncope - For Health Professionals - For the Public - sanofi-aventis Canada Inc. Date: 2006-10-03
	Important Safety Information on Gleevec (imatinib mesylate) - For Health Professionals - For the Public - Novartis Pharmaceuticals Canada Inc. Date: 2006-10-02

September

	Important Safety Information on the Alaris SE Pump (formerly Signature Edition Infusion Pump) - Notice to Hospitals - Cardinal Health Date: 2006-09-19
	Important Safety Information on the recall of the Mallinckrodt Satin-Slip Intubating Stylet - 6 FR - Notice to Hospitals - Tyco Healthcare Canada Date: 2006-09-14

August

	Association of a Rapamune (sirolimus) containing immunosuppressant regimen with a high rate of acute rejection in de novo renal transplant patients - For Health Professionals - For the Public - Wyeth Pharmaceuticals Date: 2006-08-24
	Association of Lamictal (lamotrigine) with an increased risk of non-syndromic oral clefts - For Health Professionals - For the Public - GlaxoSmithKline Inc. Date: 2006-08-08

July

	Possible Association of Remicade (infliximab) with hepatosplenic T-cell lymphoma in pediatric and young adult patients with Crohn's disease - For Health Professionals - For the Public - Schering Canada Inc. Date: 2006-07-27
	Important Safety Information on certain Guidant/Boston Scientific pacemakers and defibrillators - For Health Professionals - Guidant Canada Corporation Date: 2006-07-19
	Association of Nephrogenic Systemic Fibrosis / Nephrogenic Fibrosing Dermopathy (NSF/NFD) with the use of gadolinium (Omniscan) - For Health Professionals - GE Healthcare Canada Inc. Date: 2006-07-17
	Important Safety Information on Specific lots of Comfort Shield Incontinence Care Washcloths - Notice to Hospitals - For the Public (2006-06-28) - Source Medical Corporation Date: 2006-07-11
	Important Safety Information Regarding Intracranial Hemorrhage in Patients Receiving Aptivus (tipranavir) Capsules - For Health Professionals - For the Public - Boehringer Ingelheim (Canada) Ltd Date: 2006-07-05

June

	Important Safety Information on Anzemet (dolasetron mesylate): New Contraindications - Notice to Hospitals Date: 2006-06-30
	Association of the erectile dysfunction medications Cialis (tadalafil), Levitra (vardenafil hydrochloride) and Viagra (sildenafil citrate) with visual problems - For Health Professionals - For the Public - Eli Lilly Canada Inc. - Bayer Inc. - Pfizer Canada Inc. Date: 2006-06-28
	Recall of certain lots of SureStep Blood Glucose Meters - For Health Professionals - Notice to Hospitals - For the Public - LifeScan Canada Ltd. Date: 2006-06-22
	Important Safety and Efficacy Information on Iressa (gefitinib) 250 mg Tablets - For Health Professionals - For the Public - AstraZeneca Canada Inc. Date: 2006-06-05

May

	Updating of Product Monograph of Attention Deficit Hyperactivity Disorder (ADHD) Drugs - For Health Professionals - For the Public Date: 2006-05-26
	Important Safety Information on Evista (raloxifene hydrochloride) - For Health Professionals - For the Public - Eli Lilly Canada Inc Date: 2006-05-25

	Update regarding the association of Tequin (gatifloxacin) with serious hypoglycemia and hyperglycemia - For Health Professionals - For the Public - Bristol-Myers Squibb Canada Date: 2006-05-17
	Important Safety Information on the Colleague Volumetric Infusion Pump -Baxter Corporation Date: 2006-05-04

April

Important Safety Information on the recall of Segufix-Standard and Segufix-Simplex - Segufix Systems Ltd. Date: 2006-04-28

March

	Important Safety Information on the recall of Adult Respiratory Ventilator Circuits - Source Medical Corporation Date: 2006-03-22
	Important Safety Information on the Potential Delivery of Unrequested Patient-Controlled Analgesia (PCA) Infusion Pump Doses - Baxter Corporation Date: 2006-03-16
	Important Safety Information on Interference with Medical Telemetry Systems - Notice to Hospitals Date: 2006-03-14
	Potential Risk of Cutaneous Vasculitic Toxicities associated with the use of Hydrea (hydroxyurea capsules) - Bristol-Myers Squibb Canada Date: 2006-03-07

February

	Important Safety Information on Trasylol - Bayer Inc. Date: 2006-02-28
	Important Safety Information on Reprocessing of Mercury-Filled Esophageal Dilators - Notice to Hospitals Date: 2006-02-22
	Important Safety Information on Octreotide Acetate Omega - Omega Laboratories, Ltd Date: 2006-02-15
	Important Safety Information on certain Implantable Pacemakers - Guidant Canada Corporation Date: 2006-02-09
	Important safety information on the Colleague Volumetric Infusion Pump - For Health Professionals - Baxter Corporation Date: 2006-02-07
	Important safety information concerning certain ACCU-CHEK Aviva glucose monitors. - For Health Professionals - For the Public - Roche Diagnostics Date: 2006-02-01

January

	Association of WinRho SDF [Rho(D) Immune Globulin (Human)] with Intravascular Hemolysis in the treatment of Immune Thrombocytopenic Purpura - Notice to Hospitals - For the Public - Cangene Corporation Date: 2006-01-26
	Association of Macugen (pegaptanib sodium injection) with hypersensitivity reactions - For Health Professionals - For the Public - Pfizer Canada Inc. Date: 2006-01-23
	Important Safety Information on anti-TNFα Therapy: ENBREL (etanercept), HUMIRA (adalimumab), and REMICADE (infliximab) - For Health Professionals - For the Public - Amgen Canada, Inc., Abbott Laboratories, Ltd., and Schering Canada, Inc. Date: 2006-01-18
	Association of Blood Lancing Devices with Transmission of Blood-Borne Diseases - Notice to Hospitals Date: 2006-01-13